Improved heat shock protein-based vaccines and immunotherapies

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 19/00 (2006.01) A61K 38/17 (2006.01) A61K 39/00 (2006.01) A61P 31/00 (2006.01) A61P 35/00 (2006.01) C07K 5/068 (2006.01) C07K 5/08 (2006.01) C07K 5/10 (2006.01) C07K 5/107 (2006.01) C07K 14/705 (2006.01)

Patent

CA 2521809

Hybrid antigens comprising at least one antigenic domain, at least one heat shock protein binding domain, and at least one improved peptide linker there between are described which are useful for the induction of an immune response to the antigenic domain when administered alone or in a complex with at least one heat shock protein. The hybrid antigens and complexes can be used to treat infectious diseases and cancers that express an antigen of the antigenic domain.

La présente invention concerne des antigènes hybrides comportant au moins un domaine antigénique, au moins un domaine de liaison à des protéines de choc thermique, et au moins un lieur peptidique amélioré entre les deux domaines, lesdits antigènes s'avérant utiles pour l'induction d'une réponse immunitaire vis-à-vis du domaine antigénique lorsqu'ils sont administrés seuls ou dans un complexe avec au moins une protéine de choc thermique. Ces antigènes hybrides et les complexes associés peuvent être utilisés pour traiter des maladies infectieuses et des cancers qui expriment un antigène du domaine antigénique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Improved heat shock protein-based vaccines and immunotherapies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Improved heat shock protein-based vaccines and immunotherapies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved heat shock protein-based vaccines and immunotherapies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1490963

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.